In this issue:
Adjuvant chemotherapy prolongs survival in mismatch repair deficient stage 3 CRC
Retrospective data shows advantage to frontline FOLFIRINOX for localized pancreatic cancer
Superior survival in female patients with localised oesophagogastric cancer but greater toxicity
Chemoradiation is associated with thoracic vertebral fractures in oesophageal cancer
Guidelines for the management of mucositis secondary to cancer therapy
Combination nivolumab and ipilimumab therapy shows promise for some patients with advanced
biliary tract
Dabrafenib plus trametinib an option for patients with progressive BRAFV600E-mutated biliary tract cancer
No benefit to second-look surgery plus HIPEC in patients with CRC at high risk of peritoneal metastases
Adjuvant chemotherapy extends survival in high-risk CRC
High mortality rates in patients with metastatic CRC treated with upfront combination chemotherapy
Please login below to download this issue (PDF)